In 2025, it was estimated that there would be over 972 thousand new cancer cases among women in the United States. This statistic illustrates the estimated number of new cancer cases and deaths in the United States for 2025, by gender.

In 2022, Kentucky reported the highest cancer incidence rate in the United States, with around 512 new cases of cancer per 100,000 inhabitants. This statistic represents the U.S. states with the highest cancer incidence rates per 100,000 population in 2022.

The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).

In 2021, there were an estimated **** million new cancer cases in the United States. This statistic shows the number of cases of cancer in the United States from the year 1999 to 2021.

It is estimated that in 2025 there will be a total of 226,650 new cases of lung and bronchus cancer in the United States. The highest number of these cases are estimated to be in the state of Florida. This statistic presents the estimated number of new lung and bronchus cancer cases in the United States in 2025, by state.

The graph displays the total number of new cancer cases in the U.S. from 1999 to 2022. The x-axis represents the years, while the y-axis shows the total number of new cancer cases reported each year. The data shows a steady increase in new cancer cases over the years, with the highest number recorded in 2021, at 1,869,872 cases. The lowest number occurred in 1999, with 1,304,271 cases. A notable dip in 2020 reflects the impact of the COVID-19 pandemic, with cases dropping to 1,718,755 before rising again in 2021. The data highlights the growing prevalence of cancer cases in the U.S. over two decades.

Editor’s Choice

• Global Breast Cancer Market size is expected to be worth around USD 49.2 Bn by 2032 from USD 19.8 Bn in 2022, growing at a CAGR of 9.8% during the forecast period from 2022 to 2032.
• Breast cancer is the most common cancer among women worldwide. In 2020, there were about 2.3 million new cases of breast cancer diagnosed globally.
• Breast cancer is the leading cause of cancer-related deaths in women. In 2020, it was responsible for approximately 685,000 deaths worldwide.
• The survival rate of breast cancer has improved over the years. In the United States, the overall five-year survival rate of breast cancer is around 90%.
• The American Cancer Society recommends annual mammograms starting at age 40 for women at average risk.
• Although rare, breast cancer also occurs in men. Less than 1% of breast cancer cases are diagnosed in males.

(Source: WHO, American Cancer Society)

The US Cancer Incidence Rates dataset includes data about cancer occurrence estimates for various cancer sites among men and women under age 18 in the United States by race and Hispanic origin between 1990 and 2014.

Users can access data about cancer statistics in the United States including but not limited to searches by type of cancer and race, sex, ethnicity, age at diagnosis, and age at death. Background Surveillance Epidemiology and End Results (SEER) database’s mission is to provide information on cancer statistics to help reduce the burden of disease in the U.S. population. The SEER database is a project to the National Cancer Institute. The SEER database collects information on incidence, prevalence, and survival from specific geographic areas representing 28 percent of the United States population. User functionality Users can access a variety of reso urces. Cancer Stat Fact Sheets allow users to look at summaries of statistics by major cancer type. Cancer Statistic Reviews are available from 1975-2008 in table format. Users are also able to build their own tables and graphs using Fast Stats. The Cancer Query system provides more flexibility and a larger set of cancer statistics than F ast Stats but requires more input from the user. State Cancer Profiles include dynamic maps and graphs enabling the investigation of cancer trends at the county, state, and national levels. SEER research data files and SEER*Stat software are available to download through your Internet connection (SEER*Stat’s client-server mode) or via discs shipped directly to you. A signed data agreement form is required to access the SEER data Data Notes Data is available in different formats depending on which type of data is accessed. Some data is available in table, PDF, and html formats. Detailed information about the data is available under “Data Documentation and Variable Recodes”.

Content

In this dataset you'll find tons of different stats on cancer across the United States of America.

Acknowledgements

This data comes from https://data.world/dartmouthatlas/cancer-patients-death.

The graph illustrates the number of deaths from cancer in the United States over the period from 1999 to 2023. The x-axis represents the years, labeled with two-digit abbreviations from '99 to '23, while the y-axis displays the annual number of cancer-related deaths. Throughout this 25-year span, the number of deaths ranges from a minimum of 549,829 in 1999 to a maximum of 613,349 in 2023. The data shows a gradual increase in annual deaths over the years. Notably, the number surpassed 550,000 in 2000 with 553,080 deaths, reached 574,738 in 2010, and exceeded 600,000 in 2020 with 602,347 deaths. The figures continued to rise, culminating in the highest recorded number of 613,349 deaths in 2023.

Cancer survival statistics are typically expressed as the proportion of patients alive at some point subsequent to the diagnosis of their cancer. Statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer.

This statistic shows the rate of new cancer cases in the United States from 1999 to 2021, per every age-adjusted 100,000 population. The maximum rate of new cancer cases in the given period was *****, reported in 2001, while the minimum rate was ***** which was reported in 2020.

Users can download the data set and static graphs, tables and charts regarding cancers in the United States. Background The United States Cancer Statistics is web-based report created by the Centers for Disease Control and Prevention, in partnership with the National Cancer Institute (NCI) and the North American Association of Central Cancer Registries (NAACCR). The site contains cancer incidence and cancer mortality data. Specific information includes: the top ten cancers, state vs. national comparisons, selected cancers, childhood cancer, cancers grouped by state/ region, cancers gr ouped by race/ ethnicity and brain cancers by tumor type. User Functionality Users can view static graphs, tables and charts, which can be downloaded. Within childhood cancer, users can view by year and by cancer type and age group or by cancer type and racial/ ethnic group. Otherwise, users can view data by female, male or male and female. Users may also download the entire data sets directly. Data Notes The data sources for the cancer incidence data are the CD C's National Program for Cancer Registries (NPCR) and NCI's Surveillance, Epidemiology and End Result (SEER). CDC's National Vital Statistics System (NVSS) collects the data on cancer mortality. Data is available for each year between 1999 and 2007 or for 2003- 2007 combined. The site does not specify when new data becomes available.

Population based cancer incidence rates were abstracted from National Cancer Institute, State Cancer Profiles for all available counties in the United States for which data were available. This is a national county-level database of cancer data that are collected by state public health surveillance systems. All-site cancer is defined as any type of cancer that is captured in the state registry data, though non-melanoma skin cancer is not included. All-site age-adjusted cancer incidence rates were abstracted separately for males and females. County-level annual age-adjusted all-site cancer incidence rates for years 2006–2010 were available for 2687 of 3142 (85.5%) counties in the U.S. Counties for which there are fewer than 16 reported cases in a specific area-sex-race category are suppressed to ensure confidentiality and stability of rate estimates; this accounted for 14 counties in our study. Two states, Kansas and Virginia, do not provide data because of state legislation and regulations which prohibit the release of county level data to outside entities. Data from Michigan does not include cases diagnosed in other states because data exchange agreements prohibit the release of data to third parties. Finally, state data is not available for three states, Minnesota, Ohio, and Washington. The age-adjusted average annual incidence rate for all counties was 453.7 per 100,000 persons. We selected 2006–2010 as it is subsequent in time to the EQI exposure data which was constructed to represent the years 2000–2005. We also gathered data for the three leading causes of cancer for males (lung, prostate, and colorectal) and females (lung, breast, and colorectal). The EQI was used as an exposure metric as an indicator of cumulative environmental exposures at the county-level representing the period 2000 to 2005. A complete description of the datasets used in the EQI are provided in Lobdell et al. and methods used for index construction are described by Messer et al. The EQI was developed for the period 2000– 2005 because it was the time period for which the most recent data were available when index construction was initiated. The EQI includes variables representing each of the environmental domains. The air _domain includes 87 variables representing criteria and hazardous air pollutants. The water _domain includes 80 variables representing overall water quality, general water contamination, recreational water quality, drinking water quality, atmospheric deposition, drought, and chemical contamination. The land _domain includes 26 variables representing agriculture, pesticides, contaminants, facilities, and radon. The built _domain includes 14 variables representing roads, highway/road safety, public transit behavior, business environment, and subsidized housing environment. The sociodemographic environment includes 12 variables representing socioeconomics and crime. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Human health data are not available publicly. EQI data are available at: https://edg.epa.gov/data/Public/ORD/NHEERL/EQI. Format: Data are stored as csv files. This dataset is associated with the following publication: Jagai, J., L. Messer, K. Rappazzo , C. Gray, S. Grabich , and D. Lobdell. County-level environmental quality and associations with cancer incidence#. Cancer. John Wiley & Sons Incorporated, New York, NY, USA, 123(15): 2901-2908, (2017).

The graph displays cancer mortality rates by gender in the United States from 1999 to 2023. The x-axis represents the years, labeled from '99 to '23, while the y-axis indicates the mortality rates per 100,000 population for males, females, and the total population. Over this 24-year span, male mortality rates declined from a high of 252.8 in 1999 to a low of 165.4 in 2023. Female mortality rates decreased from 167.2 in 1999 to 123.6 in 2023. The total mortality rate dropped from 200.7 in 1999 to 141.5 in 2023. The data shows a consistent downward trend in cancer mortality rates for both genders and overall. The graph is presented in a line chart format, highlighting the yearly changes and trends in cancer mortality by gender.

This submission includes publicly available data extracted in its original form. Please reference the Related Publication listed here for source and citation information "The United States Cancer Statistics (USCS) are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI)." [Quote from: https://wonder.cdc.gov/cancer.htm]>

The rate of skin cancer in the United States increased for both sexes from 1999 to 2021, with the rate for males consistently higher than that of females. This statistic shows the incidence rate of skin cancer in the U.S. from 1999 to 2021, by gender, per 100,000 population.

Layers in this service includes: Birth, Cancer, Hospitalization Discharge, Mortality and STI Rates, as well as Demographics.

As of my last update in January 2022, I don't have access to specific real-time datasets, including a specific "US cancer analysis dataset." However, there are several well-known sources where you might find such datasets:

1. Surveillance, Epidemiology, and End Results (SEER) Program: SEER is a comprehensive source of cancer statistics in the United States, operated by the National Cancer Institute (NCI). They provide a wide range of cancer-related data including incidence, mortality, survival, and population-based data on cancer cases.

2. National Program of Cancer Registries (NPCR): This program, also managed by the Centers for Disease Control and Prevention (CDC), collects cancer incidence data at the state level.

3. CDC WONDER: The CDC's Wide-ranging Online Data for Epidemiologic Research (WONDER) platform provides access to a wide array of public health-related datasets, including cancer statistics.

4. National Cancer Database (NCDB): This database, jointly sponsored by the American College of Surgeons and the American Cancer Society, contains hospital registry data from over 1,500 Commission on Cancer (CoC)-accredited facilities.

5. National Health Interview Survey (NHIS): While not specific to cancer, the NHIS collects data on health and health-related behaviors, which may include information on cancer screenings, risk factors, and prevalence.

6. Behavioral Risk Factor Surveillance System (BRFSS): Similar to NHIS, BRFSS collects state-based, cross-sectional data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services, which may include cancer-related data.

7. National Health and Nutrition Examination Survey (NHANES): NHANES collects data on the health and nutritional status of a nationally representative sample of the U.S. population through interviews, physical examinations, and laboratory tests, which may include cancer-related information.

When accessing these datasets, it's essential to review their documentation thoroughly to understand the variables available, the methodology of data collection, any limitations or biases, and the terms of use. Additionally, many of these datasets require approval or registration before access is granted.